Business
Endexx Reports Strong Full-Year 2017 Results
Endexx Reports Strong Full-Year 2017 Results.
About this update from Endexx Corp.
[{"type":"text","content":"\n\n Company Sees Revenues Up 127% Year Over Year\n Holistic Earth Remedies LLC, Acquisition Has Generated $85-90K Annually in the Past Two Years and Will Add to Fiscal 2018 Revenues CAVE CREEK, AZ , Jan. 23, 2018 (GLOBE NEWSWIRE) -- Endexx Corporation (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, today announced financial and operational highlights for the full year ended September 30, 2017. The Company is pleased to report another record sales year for fiscal 2017. For the full year ended September 30, 2017, the Company generated $501,606 in sales, representing a 127% increase compared to the full year ended September 30, 2016. Gross profit was $289,142 for full year ended September 30, 2016, up 433% as compared to the full year ended September 30, 2016. Operating loss was $(223,754), down 71% as compared to the full year ended September 30, 2016, which contributed to the Company’s ability to reduce its operating expenses by 40%. Net loss for the full year ended September 30 was ($585,517), down from ($776,660) as compared to the full year ended September 30, 2016. Fourth Quarter 2017 Milestones and Updates: Announced new cannabidiol (CBD)-infused pain relief products, Maggie's Mist© and Maggie's Balm©, 100% organic, with premium CBDShowcased Phyto-Bites at the 4th Annual SuperZoo Show 2017Engaged Eventus Consulting, P.C., to assist with the completion of preparing accounting records for the current audit and to facilitate final preparations for the SEC registration and filing Sponsored “Athletes for Care” at the Cannabis World Congress and Business Exposition and the 3rd Annual Southwest Cannabis Conference & Expo, demonstrating the Company’s commitment in developing sustainable health solutions for athletes CEO Todd Davis said, \"2017 was an exciting year for Endexx. We successfully expanded our footprint and continued to reinforce the strength of our product launch strategy. From an industry perspective, we created additional exposure at industry conferences and within communities that not only recognized our leadership in the CBD space but also our commitment in setting the standards for high-quality therapeutic value for our customers. We plan on providing over 40 SKUs of various categories, over the next fiscal year, with...